I think if we are being real the EFS, on its initial plan, was delayed by about 1 month. Which is noting in the scheme of things and this was due to the bureaucratic nature of getting full CMS approval.
The plan was to release late breaking trial results at TCT next week which has now been moved to London Valves in November. I actually prefer LV as a venue for this presentation anyway. They always seem to put on a great conference.
AVR Price at posting:
$20.30 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)